Krause Kevin Michael (CIK 0001916925)

Latest company ownership

Role: Chief Strategy Officer
Shares held
31,914
Last filed at
Mar 29, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 9, 2024 Jan 11, 2024 AN2 Therapeutics, Inc. Chief Strategy Officer Sell 10.0 -7,417 -79.49% $149.4K
Jan 2, 2024 Jan 4, 2024 AN2 Therapeutics, Inc. Chief Strategy Officer Sell 10.0 -2,583 -57.44% $52K